Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 44 entries
Sorted by: Best Match Show Resources per page
Reduction of .

Journal of radioanalytical and nuclear chemistry

de Blois E, Chan HS, Roy K, Krenning EP, Breeman WA.
PMID: 26224908
J Radioanal Nucl Chem. 2011;288(1):303-306. doi: 10.1007/s10967-010-0915-8. Epub 2010 Dec 23.

PET with

Cite
de Blois E, Chan HS, Roy K, et al. Reduction of . J Radioanal Nucl Chem. 2010;288(1):303-306doi: 10.1007/s10967-010-0915-8.
de Blois, E., Chan, H. S., Roy, K., Krenning, E. P., & Breeman, W. A. (2011). Reduction of . Journal of radioanalytical and nuclear chemistry, 288(1), 303-306. https://doi.org/10.1007/s10967-010-0915-8
de Blois, Erik, et al. "Reduction of ." Journal of radioanalytical and nuclear chemistry vol. 288,1 (2011): 303-306. doi: https://doi.org/10.1007/s10967-010-0915-8
de Blois E, Chan HS, Roy K, Krenning EP, Breeman WA. Reduction of . J Radioanal Nucl Chem. 2011;288(1):303-306. doi: 10.1007/s10967-010-0915-8. Epub 2010 Dec 23. PMID: 26224908; PMCID: PMC4514634.
Copy Download .nbib Format: NLM
Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11-first estimates for clinical translation.

EJNMMI research

Kaloudi A, Nock BA, Lymperis E, Valkema R, Krenning EP, de Jong M, Maina T.
PMID: 26882895
EJNMMI Res. 2016 Dec;6(1):15. doi: 10.1186/s13550-015-0158-3. Epub 2016 Feb 16.

BACKGROUND: We have recently shown that treatment of mice with the neutral endopeptidase (NEP) inhibitor phosphoramidon (PA) improves the bioavailability and tumor uptake of biodegradable radiopeptides. For the truncated gastrin radiotracer [(111)In-DOTA]MG11 ([(DOTA)DGlu(10)]gastrin(10-17)), this method led to impressively high...

Cite
Kaloudi A, Nock BA, Lymperis E, et al. Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11-first estimates for clinical translation. EJNMMI Res. 2016;6(1):15doi: 10.1186/s13550-015-0158-3.
Kaloudi, A., Nock, B. A., Lymperis, E., Valkema, R., Krenning, E. P., de Jong, M., & Maina, T. (2016). Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11-first estimates for clinical translation. EJNMMI research, 6(1), 15. https://doi.org/10.1186/s13550-015-0158-3
Kaloudi, Aikaterini, et al. "Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11-first estimates for clinical translation." EJNMMI research vol. 6,1 (2016): 15. doi: https://doi.org/10.1186/s13550-015-0158-3
Kaloudi A, Nock BA, Lymperis E, Valkema R, Krenning EP, de Jong M, Maina T. Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11-first estimates for clinical translation. EJNMMI Res. 2016 Dec;6(1):15. doi: 10.1186/s13550-015-0158-3. Epub 2016 Feb 16. PMID: 26882895; PMCID: PMC4755954.
Copy Download .nbib Format: NLM
Surgical education and training at the crossroads between medical school and residency.

Bulletin of the American College of Surgeons

Kulaylat AN, McKinley SK, Kenning EM, Zheng F.
PMID: 25145044
Bull Am Coll Surg. 2014 Aug;99(8):24-9.

No abstract available.

Cite
Kulaylat AN, McKinley SK, Kenning EM, et al. Surgical education and training at the crossroads between medical school and residency. Bull Am Coll Surg. 2014;99(8):24-9
Kulaylat, A. N., McKinley, S. K., Kenning, E. M., & Zheng, F. (2014). Surgical education and training at the crossroads between medical school and residency. Bulletin of the American College of Surgeons, 99(8), 24-9.
Kulaylat, Afif N, et al. "Surgical education and training at the crossroads between medical school and residency." Bulletin of the American College of Surgeons vol. 99,8 (2014): 24-9.
Kulaylat AN, McKinley SK, Kenning EM, Zheng F. Surgical education and training at the crossroads between medical school and residency. Bull Am Coll Surg. 2014 Aug;99(8):24-9. PMID: 25145044.
Copy Download .nbib Format: NLM
Micromanaging cardiac regeneration: Targeted delivery of microRNAs for cardiac repair and regeneration.

World journal of cardiology

Kamps JA, Krenning G.
PMID: 26981212
World J Cardiol. 2016 Feb 26;8(2):163-79. doi: 10.4330/wjc.v8.i2.163.

The loss of cardiomyocytes during injury and disease can result in heart failure and sudden death, while the adult heart has a limited capacity for endogenous regeneration and repair. Current stem cell-based regenerative medicine approaches modestly improve cardiomyocyte survival,...

Cite
Kamps JA, Krenning G. Micromanaging cardiac regeneration: Targeted delivery of microRNAs for cardiac repair and regeneration. World J Cardiol. 2016;8(2):163-79doi: 10.4330/wjc.v8.i2.163.
Kamps, J. A., & Krenning, G. (2016). Micromanaging cardiac regeneration: Targeted delivery of microRNAs for cardiac repair and regeneration. World journal of cardiology, 8(2), 163-79. https://doi.org/10.4330/wjc.v8.i2.163
Kamps, Jan Aam, and Krenning, Guido. "Micromanaging cardiac regeneration: Targeted delivery of microRNAs for cardiac repair and regeneration." World journal of cardiology vol. 8,2 (2016): 163-79. doi: https://doi.org/10.4330/wjc.v8.i2.163
Kamps JA, Krenning G. Micromanaging cardiac regeneration: Targeted delivery of microRNAs for cardiac repair and regeneration. World J Cardiol. 2016 Feb 26;8(2):163-79. doi: 10.4330/wjc.v8.i2.163. PMID: 26981212; PMCID: PMC4766267.
Copy Download .nbib Format: NLM
The Application of Mobile fNIRS in Marketing Research-Detecting the ".

Frontiers in human neuroscience

Krampe C, Gier NR, Kenning P.
PMID: 30443210
Front Hum Neurosci. 2018 Nov 01;12:433. doi: 10.3389/fnhum.2018.00433. eCollection 2018.

Recent research in the field of "neuro-marketing" shows promise to substantially increase knowledge on marketing issues for example price-perception, advertising efficiency, branding and shopper behaviour. Recently, an innovative and mobile applicable neuroimaging method has been proposed, namely functional near-infrared...

Cite
Krampe C, Gier NR, Kenning P. The Application of Mobile fNIRS in Marketing Research-Detecting the ". Front Hum Neurosci. 2018;12:433doi: 10.3389/fnhum.2018.00433.
Krampe, C., Gier, N. R., & Kenning, P. (2018). The Application of Mobile fNIRS in Marketing Research-Detecting the ". Frontiers in human neuroscience, 12433. https://doi.org/10.3389/fnhum.2018.00433
Krampe, Caspar, et al. "The Application of Mobile fNIRS in Marketing Research-Detecting the "." Frontiers in human neuroscience vol. 12 (2018): 433. doi: https://doi.org/10.3389/fnhum.2018.00433
Krampe C, Gier NR, Kenning P. The Application of Mobile fNIRS in Marketing Research-Detecting the ". Front Hum Neurosci. 2018 Nov 01;12:433. doi: 10.3389/fnhum.2018.00433. eCollection 2018. PMID: 30443210; PMCID: PMC6222120.
Copy Download .nbib Format: NLM
In memoriam: Dirk J Kwekkeboom (1958-2017).

Endocrine-related cancer

de Herder WW, Krenning EP, Krestin GP.
PMID: 30390609
Endocr Relat Cancer. 2017 May 01;24(5):E1-E2. doi: 10.1530/ERC-17-0087.

No abstract available.

Cite
de Herder WW, Krenning EP, Krestin GP. In memoriam: Dirk J Kwekkeboom (1958-2017). Endocr Relat Cancer. 2017;24(5):E1-E2doi: 10.1530/ERC-17-0087.
de Herder, W. W., Krenning, E. P., & Krestin, G. P. (2017). In memoriam: Dirk J Kwekkeboom (1958-2017). Endocrine-related cancer, 24(5), E1-E2. https://doi.org/10.1530/ERC-17-0087
de Herder, Wouter W, et al. "In memoriam: Dirk J Kwekkeboom (1958-2017)." Endocrine-related cancer vol. 24,5 (2017): E1-E2. doi: https://doi.org/10.1530/ERC-17-0087
de Herder WW, Krenning EP, Krestin GP. In memoriam: Dirk J Kwekkeboom (1958-2017). Endocr Relat Cancer. 2017 May 01;24(5):E1-E2. doi: 10.1530/ERC-17-0087. PMID: 30390609.
Copy Download .nbib Format: NLM
Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands.

Pharmaceutics

Kanellopoulos P, Kaloudi A, Jong M, Krenning EP, Nock BA, Maina T.
PMID: 32526874
Pharmaceutics. 2020 Jun 09;12(6). doi: 10.3390/pharmaceutics12060528.

Neurotensin subtype 1 receptors (NTS1R) represent attractive molecular targets for directing radiolabeled neurotensin (NT) analogs to tumor lesions for diagnostic and therapeutic purposes. This approach has been largely undermined by the rapid in vivo degradation of linear NT-based radioligands....

Cite
Kanellopoulos P, Kaloudi A, Jong M, et al. Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands. Pharmaceutics. 2020;12(6)doi: 10.3390/pharmaceutics12060528.
Kanellopoulos, P., Kaloudi, A., Jong, M., Krenning, E. P., Nock, B. A., & Maina, T. (2020). Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands. Pharmaceutics, 12(6), . https://doi.org/10.3390/pharmaceutics12060528
Kanellopoulos, Panagiotis, et al. "Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands." Pharmaceutics vol. 12,6 (2020). doi: https://doi.org/10.3390/pharmaceutics12060528
Kanellopoulos P, Kaloudi A, Jong M, Krenning EP, Nock BA, Maina T. Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands. Pharmaceutics. 2020 Jun 09;12(6). doi: 10.3390/pharmaceutics12060528. PMID: 32526874; PMCID: PMC7356968.
Copy Download .nbib Format: NLM
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasia: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogues.

Neuroendocrinology

Hicks RJ, Kwekkeboom DJ, Krenning E, Bodei L, Grozinsky-Glasberg S, Arnold R, Borbath I, Cwikla J, Toumpanakis C, Kaltsas G, Davies P, Hörsch D, Tiensuu Janson E, Ramage J.
PMID: 28402980
Neuroendocrinology. 2017;105(3):295-309. doi: 10.1159/000475526. Epub 2017 Apr 13.

No abstract available.

Cite
Hicks RJ, Kwekkeboom DJ, Krenning E, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasia: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogues. Neuroendocrinology. 2017;105(3):295-309doi: 10.1159/000475526.
Hicks, R. J., Kwekkeboom, D. J., Krenning, E., Bodei, L., Grozinsky-Glasberg, S., Arnold, R., Borbath, I., Cwikla, J., Toumpanakis, C., Kaltsas, G., Davies, P., Hörsch, D., Tiensuu Janson, E., Ramage, J. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasia: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogues. Neuroendocrinology, 105(3), 295-309. https://doi.org/10.1159/000475526
Hicks, Rodney J, et al. "ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasia: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogues." Neuroendocrinology vol. 105,3 (2017): 295-309. doi: https://doi.org/10.1159/000475526
Hicks RJ, Kwekkeboom DJ, Krenning E, Bodei L, Grozinsky-Glasberg S, Arnold R, Borbath I, Cwikla J, Toumpanakis C, Kaltsas G, Davies P, Hörsch D, Tiensuu Janson E, Ramage J. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasia: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogues. Neuroendocrinology. 2017;105(3):295-309. doi: 10.1159/000475526. Epub 2017 Apr 13. PMID: 28402980.
Copy Download .nbib Format: NLM
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging.

Neuroendocrinology

Sundin A, Arnold R, Baudin E, Cwikla JB, Eriksson B, Fanti S, Fazio N, Giammarile F, Hicks RJ, Kjaer A, Krenning E, Kwekkeboom D, Lombard-Bohas C, O'Connor JM, O'Toole D, Rockall A, Wiedenmann B, Valle JW, Vullierme MP.
PMID: 28355596
Neuroendocrinology. 2017;105(3):212-244. doi: 10.1159/000471879. Epub 2017 Mar 30.

No abstract available.

Cite
Sundin A, Arnold R, Baudin E, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging. Neuroendocrinology. 2017;105(3):212-244doi: 10.1159/000471879.
Sundin, A., Arnold, R., Baudin, E., Cwikla, J. B., Eriksson, B., Fanti, S., Fazio, N., Giammarile, F., Hicks, R. J., Kjaer, A., Krenning, E., Kwekkeboom, D., Lombard-Bohas, C., O'Connor, J. M., O'Toole, D., Rockall, A., Wiedenmann, B., Valle, J. W., Vullierme, M. P. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging. Neuroendocrinology, 105(3), 212-244. https://doi.org/10.1159/000471879
Sundin, Anders, et al. "ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging." Neuroendocrinology vol. 105,3 (2017): 212-244. doi: https://doi.org/10.1159/000471879
Sundin A, Arnold R, Baudin E, Cwikla JB, Eriksson B, Fanti S, Fazio N, Giammarile F, Hicks RJ, Kjaer A, Krenning E, Kwekkeboom D, Lombard-Bohas C, O'Connor JM, O'Toole D, Rockall A, Wiedenmann B, Valle JW, Vullierme MP. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging. Neuroendocrinology. 2017;105(3):212-244. doi: 10.1159/000471879. Epub 2017 Mar 30. PMID: 28355596.
Copy Download .nbib Format: NLM
Glomerular Endothelial Cells as Instigators of Glomerular Sclerotic Diseases.

Frontiers in pharmacology

Sol M, Kamps JAAM, van den Born J, van den Heuvel MC, van der Vlag J, Krenning G, Hillebrands JL.
PMID: 33123011
Front Pharmacol. 2020 Oct 06;11:573557. doi: 10.3389/fphar.2020.573557. eCollection 2020.

Glomerular endothelial cell (GEnC) dysfunction is important in the pathogenesis of glomerular sclerotic diseases, including Focal Segmental Glomerulosclerosis (FSGS) and overt diabetic nephropathy (DN). GEnCs form the first cellular barrier in direct contact with cells and factors circulating in...

Cite
Sol M, Kamps JAAM, van den Born J, et al. Glomerular Endothelial Cells as Instigators of Glomerular Sclerotic Diseases. Front Pharmacol. 2020;11:573557doi: 10.3389/fphar.2020.573557.
Sol, M., Kamps, J. A. A. M., van den Born, J., van den Heuvel, M. C., van der Vlag, J., Krenning, G., & Hillebrands, J. L. (2020). Glomerular Endothelial Cells as Instigators of Glomerular Sclerotic Diseases. Frontiers in pharmacology, 11573557. https://doi.org/10.3389/fphar.2020.573557
Sol, Marloes, et al. "Glomerular Endothelial Cells as Instigators of Glomerular Sclerotic Diseases." Frontiers in pharmacology vol. 11 (2020): 573557. doi: https://doi.org/10.3389/fphar.2020.573557
Sol M, Kamps JAAM, van den Born J, van den Heuvel MC, van der Vlag J, Krenning G, Hillebrands JL. Glomerular Endothelial Cells as Instigators of Glomerular Sclerotic Diseases. Front Pharmacol. 2020 Oct 06;11:573557. doi: 10.3389/fphar.2020.573557. eCollection 2020. PMID: 33123011; PMCID: PMC7573930.
Copy Download .nbib Format: NLM
Thoracic bilateral sympathectomy attenuates oxidative stress and prevents ventricular remodelling in experimental pulmonary hypertension.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Coutinho E Silva RDS, Wiggenhauser LM, Simas R, Zanoni FL, Medeiros G, da Silva FB, Ogata DC, Breithaupt-Faloppa AC, Krenning G, Moreira LFP.
PMID: 34957507
Eur J Cardiothorac Surg. 2021 Dec 27; doi: 10.1093/ejcts/ezab549. Epub 2021 Dec 27.

OBJECTIVES: Pulmonary arterial hypertension (PAH) is a cardiopulmonary disease that affects the pulmonary vasculature, leading to increased afterload and eventually right ventricular (RV) remodelling and failure. Bilateral sympathectomy (BS) has shown promising results in dampening cardiac remodelling and dysfunction...

Cite
Coutinho E Silva RDS, Wiggenhauser LM, Simas R, et al. Thoracic bilateral sympathectomy attenuates oxidative stress and prevents ventricular remodelling in experimental pulmonary hypertension. Eur J Cardiothorac Surg. 2021;doi: 10.1093/ejcts/ezab549.
Coutinho E Silva, R. D. S., Wiggenhauser, L. M., Simas, R., Zanoni, F. L., Medeiros, G., da Silva, F. B., Ogata, D. C., Breithaupt-Faloppa, A. C., Krenning, G., & Moreira, L. F. P. (2021). Thoracic bilateral sympathectomy attenuates oxidative stress and prevents ventricular remodelling in experimental pulmonary hypertension. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, . https://doi.org/10.1093/ejcts/ezab549
Coutinho E Silva, Raphael Dos Santos, et al. "Thoracic bilateral sympathectomy attenuates oxidative stress and prevents ventricular remodelling in experimental pulmonary hypertension." European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery vol. (2021). doi: https://doi.org/10.1093/ejcts/ezab549
Coutinho E Silva RDS, Wiggenhauser LM, Simas R, Zanoni FL, Medeiros G, da Silva FB, Ogata DC, Breithaupt-Faloppa AC, Krenning G, Moreira LFP. Thoracic bilateral sympathectomy attenuates oxidative stress and prevents ventricular remodelling in experimental pulmonary hypertension. Eur J Cardiothorac Surg. 2021 Dec 27; doi: 10.1093/ejcts/ezab549. Epub 2021 Dec 27. PMID: 34957507.
Copy Download .nbib Format: NLM
Towards prevention of ischemia-reperfusion kidney injury: Pre-clinical evaluation of 6-chromanol derivatives and the lead compound SUL-138.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Vogelaar PC, Nakladal D, Swart DH, Tkáčiková Ľ, Tkáčiková S, van der Graaf AC, Henning RH, Krenning G.
PMID: 34610451
Eur J Pharm Sci. 2022 Jan 01;168:106033. doi: 10.1016/j.ejps.2021.106033. Epub 2021 Oct 03.

Acute kidney injury (AKI) is a global healthcare burden attributable to high mortality and staggering costs of dialysis. The underlying causes of AKI include hypothermia and rewarming (H/R), ischemia/reperfusion (I/R), mitochondrial dysfunction and reactive oxygen species production. Inspired by...

Cite
Vogelaar PC, Nakladal D, Swart DH, et al. Towards prevention of ischemia-reperfusion kidney injury: Pre-clinical evaluation of 6-chromanol derivatives and the lead compound SUL-138. Eur J Pharm Sci. 2021;168:106033doi: 10.1016/j.ejps.2021.106033.
Vogelaar, P. C., Nakladal, D., Swart, D. H., Tkáčiková, �. �., Tkáčiková, S., van der Graaf, A. C., Henning, R. H., & Krenning, G. (2022). Towards prevention of ischemia-reperfusion kidney injury: Pre-clinical evaluation of 6-chromanol derivatives and the lead compound SUL-138. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 168106033. https://doi.org/10.1016/j.ejps.2021.106033
Vogelaar, P C, et al. "Towards prevention of ischemia-reperfusion kidney injury: Pre-clinical evaluation of 6-chromanol derivatives and the lead compound SUL-138." European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences vol. 168 (2022): 106033. doi: https://doi.org/10.1016/j.ejps.2021.106033
Vogelaar PC, Nakladal D, Swart DH, Tkáčiková Ľ, Tkáčiková S, van der Graaf AC, Henning RH, Krenning G. Towards prevention of ischemia-reperfusion kidney injury: Pre-clinical evaluation of 6-chromanol derivatives and the lead compound SUL-138. Eur J Pharm Sci. 2022 Jan 01;168:106033. doi: 10.1016/j.ejps.2021.106033. Epub 2021 Oct 03. PMID: 34610451.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 44 entries